Watchlist Manager

Watchlist

Price: 5 900 KRW 0.34% Market Closed

Market Cap: ₩164.8B

	Dongwha Pharm Co Ltd KRX:000020	KR
	Birdman Inc TSE:7063	JP
H	Hindustan Foods Ltd NSE:HNDFDS	IN
	Mirion Technologies Inc NYSE:MIR	US
	Manolete Partners PLC LSE:MANO	UK

Balance Sheet

Currency: KRW

	Dec-2009	Dec-2010	Dec-2011	Dec-2012	Dec-2013	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023	Dec-2024
Assets
Cash & Cash Equivalents	9 516	18 141	35 134	18 119	28 164	32 623	44 890	35 731	31 589	40 614	37 779	58 596	60 480	34 347	72 317	25 656
Cash	0	0	0	98	190	349	210	102	70	50	43	9	16	4	276	323
Cash Equivalents	9 516	18 141	35 134	18 021	27 974	32 274	44 680	35 629	31 519	40 564	37 736	58 587	60 464	34 343	72 041	25 334
Short-Term Investments	6 466	1 920	1 920	16 020	2 068	2 103	2 087	29 920	93 923	63 052	82 240	55 134	58 730	66 527	14 917	17 838
Total Receivables	51 673	65 435	62 809	55 206	54 588	56 032	57 570	57 827	66 864	79 450	80 152	61 932	61 094	69 814	74 368	100 515
Accounts Receivables	46 516	61 792	58 469	50 586	49 869	51 641	52 900	53 922	61 980	73 723	71 331	58 020	56 518	61 752	65 263	78 811
Other Receivables	5 157	3 643	4 340	4 620	4 719	4 391	4 670	3 905	4 884	5 727	8 821	3 912	4 576	8 062	9 105	21 704
Inventory	35 856	37 128	32 163	31 594	30 437	28 382	26 151	26 577	36 606	43 718	33 431	39 504	36 244	46 784	70 697	89 329
Other Current Assets	323	33 800	295	296	1 503	1 407	4 317	1 437	5 519	1 053	1 856	7 577	3 651	10 055	5 400	4 468
Total Current Assets	103 835	156 425	132 321	121 236	116 760	120 548	135 015	151 492	234 500	227 887	235 457	222 743	220 199	227 527	237 700	237 806
PP&E Net	161 046	157 023	188 284	183 872	171 902	161 854	151 777	142 171	103 746	96 772	99 215	130 951	142 851	151 153	188 330	219 546
PP&E Gross	161 046	157 023	188 284	183 872	171 902	161 854	151 777	142 171	103 746	96 772	99 215	130 951	142 851	151 153	188 330	219 546
Accumulated Depreciation	28 105	33 892	49 969	60 532	71 128	81 438	92 076	102 184	103 012	112 729	122 257	138 803	143 009	150 135	164 613	177 930
Intangible Assets	4 574	6 023	5 223	4 195	8 265	7 108	6 432	6 442	6 137	5 581	5 465	12 417	13 582	11 147	25 095	58 754
Goodwill	0	0	0	0	0	0	0	0	0	0	0	4 556	4 556	4 556	24 931	24 931
Long-Term Investments	42 825	12 915	12 957	14 336	14 939	14 926	16 676	17 331	20 829	31 071	29 265	58 160	59 734	58 608	71 568	67 128
Other Long-Term Assets	1 866	958	647	647	4 299	8 638	7 287	7 169	2 013	9 287	6 627	4 981	6 883	8 146	10 896	11 470
Other Assets	0	0	0	0	0	0	0	0	0	0	0	4 556	4 556	4 556	24 931	24 931
Total Assets	314 145 N/A	333 344 +6%	339 431 +2%	324 285 -4%	316 166 -3%	313 073 -1%	317 187 +1%	324 605 +2%	367 225 +13%	370 599 +1%	376 029 +1%	433 808 +15%	447 804 +3%	461 136 +3%	558 520 +21%	619 635 +11%
Liabilities
Accounts Payable	16 553	17 923	22 057	17 645	18 496	17 980	17 170	25 672	21 776	29 965	17 323	18 522	17 119	22 232	31 412	38 865
Accrued Liabilities	1 876	6 031	6 229	6 034	5 871	7 345	8 729	8 762	9 008	9 944	12 636	11 458	13 752	14 543	15 079	15 920
Short-Term Debt	11 000	27 029	0	0	4 000	2 000	2 000	0	0	0	0	9 800	4 500	2 500	14 670	31 330
Current Portion of Long-Term Debt	20 000	0	18 500	10 000	0	2 000	0	0	0	0	1 793	2 969	3 073	3 274	5 702	7 018
Other Current Liabilities	43 256	36 244	41 074	48 920	45 006	39 590	41 251	21 018	29 932	20 889	23 963	24 745	28 018	33 013	39 271	40 878
Total Current Liabilities	92 685	87 227	87 860	82 600	73 373	68 915	69 149	55 452	60 717	60 798	55 715	67 494	66 461	75 562	106 134	134 011
Long-Term Debt	0	18 500	10 000	0	2 000	0	0	0	0	0	5 116	4 075	5 056	2 044	27 884	59 795
Deferred Income Tax	3 787	1 424	395	30	0	0	0	0	0	0	0	2 476	2 703	2 096	4 592	4 130
Minority Interest	0	0	0	0	0	0	0	0	0	310	301	11 733	13 454	14 526	31 264	28 555
Other Liabilities	5 318	9 039	11 553	14 660	13 562	14 432	17 920	16 227	9 564	12 400	14 022	16 775	13 196	2 507	16 867	19 772
Total Liabilities	101 790 N/A	116 191 +14%	109 808 -5%	97 290 -11%	88 934 -9%	83 347 -6%	87 069 +4%	71 679 -18%	70 280 -2%	73 508 +5%	75 154 +2%	102 552 +36%	100 870 -2%	96 736 -4%	186 741 +93%	246 264 +32%
Equity
Common Stock	27 931	27 931	27 931	27 931	27 931	27 931	27 931	27 931	27 931	27 931	27 931	27 931	27 931	27 931	27 931	27 931
Retained Earnings	116 700	160 057	172 752	169 661	170 147	173 104	174 195	197 196	239 898	243 147	246 728	232 628	252 712	274 356	292 327	292 370
Additional Paid In Capital	64 536	26 920	26 920	26 920	26 920	26 920	26 920	26 920	26 920	26 920	26 920	26 920	26 920	26 920	17 079	17 079
Unrealized Security Profit/Loss	3 188	2 327	2 099	2 541	2 233	1 771	2 947	2 754	4 568	1 465	1 667	46 126	40 777	36 658	35 612	36 152
Treasury Stock	0	0	0	0	0	0	1 961	1 961	2 521	2 521	2 521	2 521	1 965	1 965	1 663	1 663
Other Equity	0	81	79	59	0	0	85	85	149	149	149	172	559	501	493	1 502
Total Equity	212 356 N/A	217 154 +2%	229 624 +6%	226 995 -1%	227 231 +0%	229 726 +1%	230 118 +0%	252 925 +10%	296 945 +17%	297 091 +0%	300 875 +1%	331 256 +10%	346 935 +5%	364 400 +5%	371 780 +2%	373 371 +0%
Total Liabilities & Equity	314 145 N/A	333 344 +6%	339 431 +2%	324 285 -4%	316 166 -3%	313 073 -1%	317 187 +1%	324 605 +2%	367 225 +13%	370 599 +1%	376 029 +1%	433 808 +15%	447 804 +3%	461 136 +3%	558 520 +21%	619 635 +11%
Shares Outstanding
Common Shares Outstanding	28	28	28	28	28	28	28	28	28	28	28	28	28	28	28	28

Income Statement Balance Sheet Cash Flow Statement

Dongwha Pharm Co Ltd
KRX:000020

Balance Sheet

Balance Sheet Decomposition
Dongwha Pharm Co Ltd

Balance Sheet
Dongwha Pharm Co Ltd

See Also

Company

Help

Tools

Stocks

Dongwha Pharm Co Ltd KRX:000020

Balance Sheet

Balance Sheet Decomposition Dongwha Pharm Co Ltd

Balance Sheet Dongwha Pharm Co Ltd

See Also

Company

Help

Tools

Stocks

Dongwha Pharm Co Ltd
KRX:000020

Balance Sheet Decomposition
Dongwha Pharm Co Ltd

Balance Sheet
Dongwha Pharm Co Ltd